Question 1

What is Prelude Therapeutics Incorporated stock price today?

Accepted Answer

The current price of PRLD is 3.72 USD — it has increased by 8.14% in the past 24 hours.

Question 2

What is Prelude Therapeutics Incorporated stock ticker?

Accepted Answer

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Prelude Therapeutics Incorporated stocks are traded under the ticker PRLD.

Question 3

When is the next Prelude Therapeutics Incorporated earnings date?

Accepted Answer

Prelude Therapeutics Incorporated is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

Question 4

How volatile is PRLD stock?

Accepted Answer

PRLD stock is 12.17% volatile and has beta coefficient of 2.46. Check out the list of the most volatile stocks — is Prelude Therapeutics Incorporated there?

Question 5

What is Prelude Therapeutics Incorporated stock price forecast for the next year?

Accepted Answer

One year price forecast for Prelude Therapeutics Incorporated has a max estimate of 7.00 USD and a min estimate of 3.00 USD.

Question 6

What were Prelude Therapeutics Incorporated earnings last quarter?

Accepted Answer

PRLD earnings for the last quarter are −0.45 USD per share, whereas the estimation was −0.58 USD resulting in a 22.86% surprise. The estimated earnings for the next quarter are −0.49 USD per share. See more details about Prelude Therapeutics Incorporated earnings.

Question 7

What is Prelude Therapeutics Incorporated revenue for the last quarter?

Accepted Answer

Prelude Therapeutics Incorporated revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 0 USD.

Question 8

Does Prelude Therapeutics Incorporated release reports?

Accepted Answer

Yes, you can track Prelude Therapeutics Incorporated financials in yearly and quarterly reports right on TradingView.

Question 9

Is Prelude Therapeutics Incorporated stock price growing?

Accepted Answer

PRLD stock has fallen by 29.41% compared to the previous week, the month change is a 24.70% fall, over the last year Prelude Therapeutics Incorporated has showed a 43.21% decrease.

Question 10

What is PRLD net income for the last quarter?

Accepted Answer

PRLD net income for the last quarter is ‪−33.08 M‬ USD, while the quarter before that showed ‪−30.61 M‬ USD of net income which accounts for −8.06% change. Track more Prelude Therapeutics Incorporated financial stats to get the full picture.

Question 11

What is Prelude Therapeutics Incorporated market cap?

Accepted Answer

Today Prelude Therapeutics Incorporated has the market capitalization of ‪233.13 M‬, it has increased by 1.73% over the last week.

Question 12

Does Prelude Therapeutics Incorporated pay dividends?

Accepted Answer

No, PRLD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Question 13

How to buy Prelude Therapeutics Incorporated stocks?

Accepted Answer

Like other stocks, PRLD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Prelude Therapeutics Incorporated stock right from TradingView charts — choose your broker and connect to your account.

Question 14

What are Prelude Therapeutics Incorporated stock highest and lowest prices ever?

Accepted Answer

PRLD reached its all-time high on Feb 10, 2021 with the price of 95.38 USD, and its all-time low was 1.66 USD and was reached on Nov 1, 2023.
See other stocks reaching their highest and lowest prices.

Question 15

How many employees does Prelude Therapeutics Incorporated have?

Accepted Answer

As of Apr 19, 2024, the company has 128.00 employees. See our rating of the largest employees — is Prelude Therapeutics Incorporated on this list?

Question 16

Should I invest in Prelude Therapeutics Incorporated stock?

Accepted Answer

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Prelude Therapeutics Incorporated technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Prelude Therapeutics Incorporated stock shows the sell signal. See more of Prelude Therapeutics Incorporated technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

Question 17

What is PRLD stock forecast?

Accepted Answer

We've gathered analysts' opinions on Prelude Therapeutics Incorporated future price: according to them, PRLD price has a max estimate of 7.00 USD and a min estimate of 3.00 USD. Read a more detailed Prelude Therapeutics Incorporated forecast: see what analysts think of Prelude Therapeutics Incorporated and suggest that you do with its stocks.

Question 18

What is Prelude Therapeutics Incorporated EBITDA?

Accepted Answer

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Prelude Therapeutics Incorporated EBITDA is ‪−130.23 M‬ USD, and current EBITDA margin is 0%. See more stats in Prelude Therapeutics Incorporated financial statements.

Prelude Therapeutics Incorporated

Price target

Analyst rating

EPS

Revenue